Risk assessment of coccidostatics during feed cross-contamination: animal and human health aspects.
about
Salinomycin as a drug for targeting human cancer stem cellsDrug screen targeted at Plasmodium liver stages identifies a potent multistage antimalarial drugComparative studies of salinomycin-loaded nanoparticles prepared by nanoprecipitation and single emulsion method.Dose-dependent adverse effects of salinomycin on male reproductive organs and fertility in mice.Maduramicin inhibits proliferation and induces apoptosis in myoblast cellsMaduramicin Rapidly Eliminates Malaria Parasites and Potentiates the Gametocytocidal Activity of the Pyrazoleamide PA21A050.Halofuginone suppresses growth of human uterine leiomyoma cells in a mouse xenograft modelReference gene selection for the shell gland of laying hens in response to time-points of eggshell formation and nicarbazin.Chronic exposure of low dose salinomycin inhibits MSC migration capability in vitro.Salinomycin and other ionophores as a new class of antimalarial drugs with transmission-blocking activity.Determination of regulatory ionophore coccidiostat residues in feedstuffs at carry-over levels by liquid chromatography-mass spectrometryPerspectives in Veterinary Pharmacology and Toxicology.Influence of three coccidiostats on the pharmacokinetics of florfenicol in rabbits.Statement on the update of the list of QPS‐recommended biological agents intentionally added to food or feed as notified to EFSA 1: Suitability of taxonomic units notified to EFSA until October 2014Maduramicin induces apoptosis and necrosis, and blocks autophagic flux in myocardial H9c2 cells.Development of an Analytical Procedure for the Determination of Multiclass Compounds for Forensic Veterinary Toxicology.
P2860
Q21285139-BC8078A1-9DCE-4B9F-992A-21BB4A3AD15DQ24613311-AAA72DB2-D65B-466D-BC40-32E7B762FE39Q34050176-5CE66CA0-C1D7-418C-A949-B4A80B1A12B2Q34809302-244D7B20-9566-4680-B2B4-193699EE3173Q35532104-622E5420-FD92-4E34-AD32-FD8CEAAF8A5EQ36644774-66E10A06-A05B-43B2-820E-A68036094F32Q36991838-6ED1217A-087F-4841-BB6F-8A0FC420A75BQ38696652-020C7E73-94AD-41A3-8340-99EA76E82394Q38718084-C55F2062-6701-44CA-BEC5-F3D4D27DDF0DQ38866063-D6C38579-3E7A-4CF0-990E-303E73B0988BQ41326700-D168ED95-041C-407D-BD7D-29158D19B642Q42395872-BC61FB59-B77F-48E3-8F0D-ACA71D92B7B2Q42672906-5511A4C6-65FB-444B-B4EB-9CACD22C71A8Q47163148-FA76A600-251F-445B-BFD8-1E5B6F4CABBAQ47630946-855B439E-EC4A-4766-86CF-57B261313B16Q52763785-6771F12E-99AF-420F-8AE5-24D9AE1CAAA0
P2860
Risk assessment of coccidostatics during feed cross-contamination: animal and human health aspects.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Risk assessment of coccidostat ...... imal and human health aspects.
@en
Risk assessment of coccidostat ...... imal and human health aspects.
@nl
type
label
Risk assessment of coccidostat ...... imal and human health aspects.
@en
Risk assessment of coccidostat ...... imal and human health aspects.
@nl
prefLabel
Risk assessment of coccidostat ...... imal and human health aspects.
@en
Risk assessment of coccidostat ...... imal and human health aspects.
@nl
P2093
P50
P1476
Risk assessment of coccidostat ...... nimal and human health aspects
@en
P2093
D W Renshaw
J Fink-Gremmels
J L C M Dorne
K Peltonen
U Bertelsen
P304
P356
10.1016/J.TAAP.2010.12.014
P577
2011-01-06T00:00:00Z